Ganga Pharmaceuticals Ltd — Important, 07-11-2025: Company Update

Ganga Pharmaceuticals Limited reported no deviation in the utilization of funds raised through equity shares upon Convertible Warrants from a Preferential Issue. The company raised Rs. 1.13 Cr and has utilized Rs. 0.53 Cr towards capital expenditure, working capital, and general corporate purposes as of September 30, 2025. The remaining unutilized amount of Rs. 0.59 Cr is held in the company's current account. This confirms the funds are being deployed as originally intended, assuring shareholders about financial discipline.